Discover
Stocks
Healthcare
BIIB
BIIB
Biogen Inc
239.12
5.25
(
2.24%
)
Market Closed
Delayed Prices By NASDAQ,
in USD
Trade
Buy
BIIB
Biogen Inc
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Biogen Inc's revenues decreased by 7.36% and amounted to 10.17B. Net income increased by 71.58% to 2.96B. Net assets increased by 22.16% to 13.39B and EPS increased from 10.40 to 20.87.
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment